See the DrugPatentWatch profile for Novarel
Information regarding the approval status of Novarel is not available in the provided context.
What is Novarel?
Novarel is a brand name for a gonadotropin medication that contains human chorionic gonadotropin (hCG) [1]. It is used to treat infertility in both men and women [1]. In women, it is used to stimulate ovulation and is often prescribed as part of an in vitro fertilization (IVF) protocol [1]. In men, it is used to stimulate sperm production [1].
How does Novarel work?
Novarel mimics the action of luteinizing hormone (LH) [1]. In women, this LH surge triggers ovulation [1]. In men, hCG stimulates the Leydig cells in the testes to produce testosterone, which is essential for sperm development [1].
Who makes Novarel?
Novarel is manufactured by Actavis Pharma [2].
When does Novarel patent expire?
Information regarding the patent expiration for Novarel is not provided. However, drug patent information can be tracked on websites like DrugPatentWatch.com [3].
Are there alternatives to Novarel?
Yes, there are alternative gonadotropin medications used to treat infertility. These may include other brands of hCG or different types of injectable fertility medications such as follicle-stimulating hormone (FSH) [4]. The choice of medication depends on the specific diagnosis and treatment plan recommended by a healthcare professional.